Sorafenib hæmmede CYP2B6 og CYP2C8 in vitro, men den kliniske relevans af denne hæmning er ikke blevet evalueret.
Sorafenib inhibited CYP2B6 and CYP2C8 in vitro, but the clinical relevance of this inhibition has not been evaluated.